Related Experiment Video
Updated: Jun 9, 2026

06:49
A Quick Phenotypic Neurological Scoring System for Evaluating Disease Progression in the SOD1-G93A Mouse Model of ALS
Published on: October 6, 2015
19.6K
Tau P301S Transgenic Mice Develop Gait and Eye Movement Impairments That Mimic Progressive Supranuclear Palsy
Rose B Creed1,2,3, Scott C Harris4,5, Sadhana Sridhar1,2,3
1Kavli Institute for Fundamental Neuroscience, UCSF, San Francisco, CA, 94158.
Biorxiv : the Preprint Server for Biology
|October 10, 2024
Summary
This study shows the hTau.P301S mouse model exhibits key Progressive Supranuclear Palsy (PSP) symptoms, including balance and eye movement deficits, aiding PSP research.
Area of Science:
- Neuroscience
- Neurology
- Pathology
Background:
- Progressive Supranuclear Palsy (PSP) is a rare neurodegenerative disease affecting balance, gait, and eye movements.
- Tau pathology is central to PSP, but its precise role in symptoms is unclear due to limited animal models.
- Current treatments for PSP are not disease-modifying.
Purpose of the Study:
- To evaluate the hTau.P301S mouse as a model for Progressive Supranuclear Palsy (PSP).
- To assess if this mouse model recapitulates key clinical and pathological features of PSP.
Main Methods:
- The hTau.P301S mouse model was analyzed for motor and eye movement functions.
- Correlation between Tau pathology in motor control regions and observed motor deficits was investigated.
Main Results:
- The hTau.P301S mice displayed progressive impairments in balance and gait coordination.
- Deficits in fast vertical eye movements, a hallmark of PSP, were observed.
- A correlation was found between Tau pathology in motor regions and motor deficits.
Conclusions:
- The hTau.P301S mouse model effectively recapitulates critical clinical and pathological aspects of Progressive Supranuclear Palsy (PSP).
- This model offers a valuable tool for investigating PSP pathogenesis and developing potential treatments.

